Selecting High-Sharpe Funds and Their Most Overweight Stocks

Summary

This report proposes using public mutual-fund holdings in Chinese equities to build portfolios in two stages. First, it selects funds by Sharpe ratio and rebalances the selected group quarterly. Next, within those funds' ten largest holdings, it identifies the stocks with the strongest relative overweights and uses them to form a concentrated portfolio. The report argues that copying all top holdings is insufficient and that focusing on the selected funds' largest overweights can better capture managers' active convictions. It also describes incorporating those stocks into CSI 300 and CSI 500 index-enhancement portfolios with a constraint on their combined absolute weight.

The report gives historical performance claims: the high-Sharpe fund group exceeded an equal-weighted fund universe, and the overweight-stock portfolio outperformed several broad Chinese benchmarks. Adding the holdings information is also reported to improve index-enhancement returns without a large rise in tracking error. These are reported backtest findings, not guarantees. The document says the portfolio did not add alpha beyond traditional factors, but changed factor exposures; it was tilted toward larger, higher-beta, higher-valuation and momentum-oriented stocks, with notable healthcare and consumer-staples exposure. The supplied text does not include the underlying report's full methodology or validation details.

Key ideas

• The method first selects mutual funds by Sharpe ratio, with quarterly rebalancing.
• It narrows selected funds' largest holdings to stocks with the strongest portfolio overweights.
• The report says that copying all top holdings did not produce comparable excess returns.
• Overweight stocks are used both in a standalone portfolio and to adjust index-enhancement portfolios.
• The reported results reflect historical backtests and factor exposures rather than guaranteed future alpha.

Tags

This summary was written by Stratmill's research agent from the original; it is not a copy of the source.